SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-166004
Filing Date
2017-05-10
Accepted
2017-05-10 16:43:01
Documents
63
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d377332d10q.htm 10-Q 595557
2 EX-31 d377332dex31.htm EX-31 6624
3 EX-32 d377332dex32.htm EX-32 4568
  Complete submission text file 0001193125-17-166004.txt   4504526

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT mnkd-20170331.xml EX-101.INS 632703
5 XBRL TAXONOMY EXTENSION SCHEMA mnkd-20170331.xsd EX-101.SCH 59311
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnkd-20170331_cal.xml EX-101.CAL 67477
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnkd-20170331_def.xml EX-101.DEF 366511
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnkd-20170331_lab.xml EX-101.LAB 482188
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnkd-20170331_pre.xml EX-101.PRE 420768
Mailing Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355
Business Address 25134 RYE CANYON LOOP SUITE 300 VALENCIA CA 91355 6617755300
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

IRS No.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50865 | Film No.: 17831081
SIC: 2834 Pharmaceutical Preparations